NSE filing, NSE: AAVAS. Summary written from the filing by ALFA Finder's alert engine.
Aavas Financiers Ltd: key numbers
- Share price
- ₹1,116.10
- Market cap
- ₹8,850 Cr
- Revenue (annual)
- ₹2,683 Cr
- Net profit (annual)
- ₹654.9 Cr
- P/E (TTM)
- 12.6×Sector 19.7×
- Promoter holding
- 48.88%+0.00% QoQ
- FII holding
- 15.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aavas Financiers Ltd
All →Aavas Financiers Regulatory Approval
AAVAS Financiers received an IRDAI Certificate of Registration to act as a Corporate Agent, effective December 8, 2026, and perpetual subject to annual fees. The approval lets the company solicit insurance products to its customers.
- Execution
- Valid from December 08, 2026; perpetual subject to annual fee and compliance
Aavas Financiers Management Change
AAVAS Financiers accepted the resignation of Independent Director Soumya Rajan and HIA Ramachandran Venkatesh, and appointed Anjali Seth as Independent Director and Bharat Thakkar as HIA. A postal ballot for Seth's appointment was also approved.
Aavas Financiers Results Update
AAVAS Financiers released H1FY27 investor highlights, with net profit up 16.4% YoY to ₹3.5 billion. Figures come from a press release, not a full results statement.
Aavas Financiers Investor Presentation: Key Takeaways
H1FY27 PAT ₹3,528mn (+16.4% YoY); Q2FY27 PAT ₹1,815mn (+10.7% YoY). AUM ₹248bn (+16%), Q2 NIM 7.81%. Focus on 20% AUM growth.
Aavas Financiers Q2 FY27 Results: Net Profit ₹181.5 Cr, Up 10.7% YoY
Aavas Financiers Ltd reported revenue from operations of ₹736.3 Cr (+10.4% YoY) and net profit of ₹181.5 Cr (+10.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹181.5 Cr · +10.7% YoY
Aavas Financiers Debt & Borrowing: ₹7.5 Cr
Aavas Financiers completed a partial face-value redemption of Rs.7.50 Crore for its NCDs. The outstanding amount after this payment stands at Rs.52.50 Crore.
- Value
- ₹7.50 Cr
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date